Correction to: An Economic Evaluation Estimating the Clinical and Economic Burden of Increased Vancomycin-Resistant Enterococcus faecium Infection Incidence in Japan.

Sugai, Motoyuki; Yuasa, Akira; Miller, Ryan L; Vasilopoulos, Vasileios; Kurosu, Hitomi; Taie, Amer; Gordon, Jason P; Matsumoto, Tetsuya

Sugai, Motoyuki; Yuasa, Akira; Miller, Ryan L; Vasilopoulos, Vasileios; Kurosu, Hitomi; Taie, Amer; Gordon, Jason P; Matsumoto, Tetsuya.

Afiliação

Sugai M; Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Yuasa A; Pfizer Japan Inc., Shinjuku Bunka Quint Building, 3-22-7, Yoyogi, Shibuya-Ku, Tokyo, 151-8589, Japan. akira.yuasa@pfizer.com.
Miller RL; Health Economics and Outcomes Research Ltd., Cardiff, UK.
Vasilopoulos V; Health Economics and Outcomes Research Ltd., Cardiff, UK.
Kurosu H; Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Taie A; Pfizer R&D UK Limited, Tadworth, UK.
Gordon JP; Health Economics and Outcomes Research Ltd., Cardiff, UK.
Matsumoto T; Department of Infectious Diseases, School of Medicine, International University of Health and Welfare, Narita, Japan.

Infect Dis Ther ; 12(8): 2191-2192, 2023 Aug.

Article em En | MEDLINE | ID: mdl-37635180

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Incidence_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google